DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 04/25/2024 declared a dividend of $0.7700 per share

Gilead Sciences Inc (NASDAQ:GILD) on 04/25/2024 declared a dividend of $ 0.7700 per share payable on June 27, 2024 to shareholders of record as of June 14, 2024.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 4.5915322304% and has increased its dividends for 8 successive years.

Gilead Sciences Inc's market cap is $ 83,566,587,000 and has a PE ratio of 14.91. The stock price closed yesterday at $ 67.08 and has a 52 week low/high of $ 65.90 and $ 87.86.

Gilead Sciences is a biopharmaceutical company, focusing on medicines to prevent and treat diseases, including HIV, viral hepatitis and cancer. Co.'s products include: Biktarvy®, which is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), an injection for intravenous use, which is a nucleotide analog RNA polymerase inhibitor indicated for certain patients for the treatment of COVID-19 requiring hospitalization; and Epclusa®, which is an oral formulation of a once-daily single tablet regimen of sofosbuvir and velpatasvir for the treatment of chronic hepatitis C virus (HCV) infection in adults and certain pediatric patients.

For more information on Gilead Sciences Inc click here.